Menu

LivaNova PLC LIVN

Full chart Compare
Set alert

Price alert · LIVN

All alert types
91.14 USD -3.05 (-3.24%)

At closeNov 6, 2026, 7:22 AM EST

91.05 -0.09 -0.10%

Pre-market · Nov 6, 7:22 AM ET

88.81 Day range 94.22
49.73 52-week range 99.38
YTD
+48.12%
1 year
+79.37%

Revenue & Expenses

Revenue by
Cardiopulmonary → Revenue: $785.38MRevenue → Gross Profit: $939.90MGross Profit → Expenses: $939.90MRevenue → Cost of Revenue: $448.20MExpenses → Selling, General & Admin: $548.80MExpenses → Research & Development: $185.80MExpenses → Other Operating Expenses: $5.90MExpenses → Interest Expense: $49.29MExpenses → Other Expenses: $371.01MExpenses → Income Tax: $21.60MNeuromodulation → Revenue: $592.81MNet Loss → Expenses: $242.50MGross Profit$939.90MNet Loss$242.50MCost of Revenue$448.20MExpenses$1.18BSelling, General & Admin$548.80MResearch & Development$185.80MOther Operating Expenses$5.90MInterest Expense$49.29MOther Expenses$371.01MIncome Tax$21.60MRevenue$1.39BCardiopulmonary$785.38MNeuromodulation$592.81M

Latest period ending Dec 31, 2025 · select a line to chart its full history

LIVN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.39B1.25B1.15B1.02B1.04B
939.87M853.48M755.82M707.23M705.99M
199.39M129.05M-68.50M-76.75M-784.00K
-242.47M63.23M17.55M-86.25M-135.82M
-4.451.160.32-1.61-2.68
LIVN annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
635.55M723.56M577.87M515.62M207.99M
2.61B2.51B2.43B2.29B2.20B
1.41B1.19B1.15B1.09B906.31M
424.98M667.73M632.04M571.05M275.44M
1.20B1.32B1.28B1.21B1.29B
LIVN annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
254.34M183.04M74.91M69.92M102.54M
-72.91M-48.16M-40.33M-38.41M36.90M
-285.66M18.55M21.48M280.13M-181.48M
-81.05M-47.11M-34.98M-26.52M-25.48M
-88.00M145.68M62.25M307.63M-44.84M